Aim: The study presents how to characterise and describe carbohydrate metabolism using a continuous glucose monitoring system, which has been available under health insurance in Hungary since 1 January 2020, specifically for type 1 diabetes.
Methodology: The paper introduces the unified recommendations arising from the international consensus conference convened during the Advanced Technologies & Treatments for Diabetes (ATTD) 2019 congress, which pertains to the analysis of hundreds of daily glucose values. These recommendations are embodied in the Ambulatory Glucose Profile report, summarised in a sensor report in Hungarian. The presentation outlines which data and standardised indicators should be included in the report, their nature indicating the state of carbohydrate metabolism, and their suggested therapeutic values.
Findings: In addition to tissue glucose values, the sensor system provides other biomarkers of glycaemic control, offering a more objective and detailed picture of the carbohydrate metabolism status. This facilitates the assessment of the health fitness of law enforcement and defence personnel living with diabetes. The clear and structured overview in the summary report eases therapeutic decision-making and communication between patients and healthcare personnel.
Value: The article illustrates the significance and suggested interpretation of sensor data in the diabetic documentation of patients using continuous tissue glucose monitoring systems. This enables healthcare professionals in primary care to interpret the data and characterise the carbohydrate metabolism status.